Aurora Cannabis (ACB) Common Equity (2018 - 2026)

Aurora Cannabis (ACB) has reported Common Equity for 9 consecutive years, with $373.2 million the latest figure, recorded in Q1 2026.

• Quarterly Common Equity fell 5.58% year-over-year to $373.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $373.2 million (down 5.58% YoY) and the FY2026 annual result came in at $370.4 million, down 9.22% from the prior year.
• Common Equity fell to $373.2 million in Q1 2026 per ACB's latest filing, from $407.2 million in the prior quarter.
• Over the last five years, Common Equity for ACB reached as high as $860.6 million in Q1 2022 and fell as low as $362.9 million in Q1 2023.
• A 5-year average of $445.2 million and a median of $415.4 million in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity slumped 71.73% — and 2024, when it rose 16.47%.
• Year by year, Common Equity stood at $438.3 million in 2022, then declined by 6.46% to $410.0 million in 2023, then advanced by 6.92% to $438.4 million in 2024, then decreased by 7.12% to $407.2 million in 2025, then dropped by 8.34% to $373.2 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $373.2 million, $407.2 million, and $412.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.